Agilon Health (NYSE:AGL) Posts Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Agilon Health (NYSE:AGL) released its earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.09), Zacks reports. The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. Agilon Health updated its FY 2025 guidance to EPS.

Agilon Health Price Performance

Agilon Health stock traded up $0.10 during trading on Wednesday, reaching $0.83. 1,347,900 shares of the company were exchanged, compared to its average volume of 7,147,281. Agilon Health has a 52-week low of $0.71 and a 52-week high of $6.08. The company has a market capitalization of $342.73 million, a P/E ratio of -1.08 and a beta of 0.05. The stock’s 50 day simple moving average is $1.06 and its two-hundred day simple moving average is $1.86.

Institutional Investors Weigh In On Agilon Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. increased its stake in Agilon Health by 6.6% during the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock worth $21,911,000 after acquiring an additional 311,158 shares during the last quarter. Bank of America Corp DE increased its stake in Agilon Health by 6.2% during the second quarter. Bank of America Corp DE now owns 3,833,330 shares of the company’s stock worth $8,817,000 after acquiring an additional 223,368 shares during the last quarter. Amundi increased its stake in Agilon Health by 20.9% during the second quarter. Amundi now owns 1,795,595 shares of the company’s stock worth $4,291,000 after acquiring an additional 310,886 shares during the last quarter. Marshall Wace LLP increased its stake in Agilon Health by 3,590.4% during the second quarter. Marshall Wace LLP now owns 1,484,114 shares of the company’s stock worth $3,413,000 after acquiring an additional 1,443,898 shares during the last quarter. Finally, Engineers Gate Manager LP increased its stake in Agilon Health by 63.1% during the second quarter. Engineers Gate Manager LP now owns 1,148,970 shares of the company’s stock worth $2,643,000 after acquiring an additional 444,358 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. Zacks Research upgraded Agilon Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 21st. Wells Fargo & Company decreased their target price on Agilon Health from $5.00 to $1.50 and set an “overweight” rating on the stock in a research report on Tuesday, October 7th. Sanford C. Bernstein restated a “market perform” rating and issued a $1.40 target price (down previously from $4.00) on shares of Agilon Health in a research report on Wednesday, August 20th. Finally, Robert W. Baird reduced their price objective on Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a research report on Thursday, August 14th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $2.81.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.